Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights

Company Overview - Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, founded in 2007 and headquartered in Cambridge, Massachusetts [4]. Financial Results Announcement - Akebia plans to release its financial results for the fourth quarter and full year ended December 31, 2024, on March 13, 2025, prior to the opening of financial markets [1]. Conference Call Details - A conference call will be held on March 13, 2024, at 8:00 a.m. ET to discuss the financial results and recent business highlights, with registration required for access [2]. - A live webcast of the conference call will be available on Akebia's website, along with an online archive of the webcast [3].